Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Treatment-Refractory Lung Rejection
NCT02181712Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2014
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial of mesenchymal stem cells in Bronchiolitis Obliterans Syndrome (BOS), sponsored by Mayo Clinic. Started Jul 2014; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT02181712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181712.